The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

Vox Sanguinis

Volumn 78, Issue 4, 2000, Pages 256-257

  Engelfriet, C P ^a   Reesink, H W ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9; PROTHROMBIN COMPLEX;

ANTIBODY PRODUCTION; BLEEDING; DRUG EFFICACY; DRUG RESPONSE; HEMOPHILIA; HUMAN; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY;

EID: 0033940503     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2000.78402561.x     Document Type: Review

References (0)